# Metabolic Syndrome Observation on a Regional Basis

> **NCT00933010** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 1600 (estimated)

## Conditions studied

- Metabolic Syndrome

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00933010
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2010-10
- **Final completion:** 2010-10
- **Target enrollment:** 1600 (ESTIMATED)
- **Last updated:** 2010-10-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00933010

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00933010, "Metabolic Syndrome Observation on a Regional Basis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00933010. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*